newsfilter
← Latest News
GlobeNewswire·

Zynerba Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference

DEVON, Pa, March 07, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for orphan neuropsychiatric disorders,